ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
bioAffinity Technologies Equity Warrants Exp 23 June 2027 Warrant
0.3100
-0.1850
-37.37%
成交量:
9,036.00
成交额:
3,820.88
市值:
882.53万
市盈率:
-0.01
高:
0.5528
开:
0.5367
低:
0.3100
收:
0.4950
52周最高:
0.8121
52周最低:
0.0525
股本:
2,846.86万
流通股本:
2,846.86万
量比:
2.07
换手率:
0.03%
股息:
- -
股息率:
- -
每股收益(TTM):
-20.7379
净资产收益率:
-301.83%
总资产收益率:
-75.63%
市净率:
1.21
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
bioAffinity Technologies启动其非侵入性Cypath®肺癌诊断技术的大规模纵向临床研究
美股速递
·
03/10
bioAffinity Technologies携手布鲁克陆军医疗中心启动验证研究,拓展Cypath® Lung无创肺癌早筛检测的样本采集选项
美股速递
·
02/25
bioAffinity Technologies宣布获得美国专利申请的允许通知,涉及其肺癌诊断算法和检测方法
美股速递
·
2025/10/16
bioAffinity Technologies, Inc.宣布完成约180万美元普通股注册直接融资,定价符合纳斯达克市场规则
美股速递
·
2025/10/09
bioAffinity Technologies宣布进行1:30反向股票拆分,将于2025年9月19日开盘时生效
美股速递
·
2025/09/17
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠:港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠:港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BIAFW/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIAFW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIAFW\",,,,,undefined,":{"symbol":"BIAFW","market":"US","secType":"STK","nameCN":"bioAffinity Technologies Equity Warrants Exp 23 June 2027 Warrant","latestPrice":0.31,"timestamp":1773864000000,"preClose":0.495,"halted":0,"volume":9036,"delay":0,"changeRate":-0.37373737373737376,"floatShares":28468614,"shares":28468614,"eps":-20.7379,"marketStatus":"盘后交易","change":-0.185,"latestTime":"03-18 16:50:12 EDT","open":0.5367,"high":0.5528,"low":0.31,"amount":3820.87957,"amplitude":0.490505,"askPrice":0.35,"askSize":3229,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-20.7379,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1773878400000},"marketStatusCode":4,"adr":0,"listingDate":1662004800000,"exchange":"NASDAQ","adjPreClose":0.495,"volumeRatio":2.073809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIAFW\",,,,,undefined,":{"symbol":"BIAFW","floatShares":28468614,"roa":"-75.63%","roe":"-301.83%","lyrEps":0,"volumeRatio":2.073809,"shares":28468614,"dividePrice":0,"high":0.5528,"amplitude":0.490505,"preClose":0.495,"low":0.31,"week52Low":0.0525,"pbRate":"1.21","psRate":"1.43","week52High":0.8121,"institutionHeld":0,"latestPrice":0.31,"committee":-1,"eps":-20.7379,"divideRate":0,"volume":9036,"delay":0,"ttmEps":-20.7379,"open":0.5367,"prevYearClose":0.35,"prevWeekClose":0.3299,"prevMonthClose":0.28,"prevQuarterClose":0.35,"fiveDayClose":0.3343,"twentyDayClose":0.2204,"sixtyDayClose":0.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIAFW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"BIAFW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIAFW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIAFW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIAFW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1158495268","title":"bioAffinity Technologies启动其非侵入性Cypath®肺癌诊断技术的大规模纵向临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1158495268","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158495268?lang=zh_cn&edition=fundamental","pubTime":"2026-03-10 19:49","pubTimestamp":1773143344,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies公司宣布,已启动一项针对其非侵入性Cypath®肺癌诊断技术的大规模纵向临床研究。该研究旨在通过长期跟踪和数据收集,进一步验证该诊断方法的有效性与可靠性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BK4139","BIAF"],"gpt_icon":0},{"id":"1186193545","title":"bioAffinity Technologies携手布鲁克陆军医疗中心启动验证研究,拓展Cypath® Lung无创肺癌早筛检测的样本采集选项","url":"https://stock-news.laohu8.com/highlight/detail?id=1186193545","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186193545?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 21:32","pubTimestamp":1772026320,"startTime":"0","endTime":"0","summary":"生物亲和技术公司(bioAffinity Technologies)宣布,将与布鲁克陆军医疗中心(Brooke Army Medical Center)合作开展一项验证研究,旨在扩大其Cypath® Lung无创早期肺癌检测技术的样本采集方式。此项研究将评估不同样本采集方案的有效性,以提升该检测技术的可及性和应用便利性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BIAFW","BK4139"],"gpt_icon":0},{"id":"1142229976","title":"bioAffinity Technologies宣布获得美国专利申请的允许通知,涉及其肺癌诊断算法和检测方法","url":"https://stock-news.laohu8.com/highlight/detail?id=1142229976","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142229976?lang=zh_cn&edition=fundamental","pubTime":"2025-10-16 20:01","pubTimestamp":1760616074,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies宣布获得美国专利申请的允许通知,涉及其肺癌诊断算法和检测方法","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BK4139","BIAF"],"gpt_icon":0},{"id":"1129857267","title":"bioAffinity Technologies, Inc.宣布完成约180万美元普通股注册直接融资,定价符合纳斯达克市场规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1129857267","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129857267?lang=zh_cn&edition=fundamental","pubTime":"2025-10-09 03:47","pubTimestamp":1759952838,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies, Inc.日前宣布完成约180万美元的注册直接融资,本次融资通过发行普通股实现,股票定价按照纳斯达克市场规则执行。\n此次融资采用按市价定价的方式进行,严格遵循纳斯达克交易所的相关规定和要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF","BIAFW"],"gpt_icon":0},{"id":"1116292885","title":"bioAffinity Technologies宣布进行1:30反向股票拆分,将于2025年9月19日开盘时生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1116292885","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116292885?lang=zh_cn&edition=fundamental","pubTime":"2025-09-17 20:16","pubTimestamp":1758111399,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies宣布进行1:30反向股票拆分,将于2025年9月19日开盘时生效","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BK4139","BIAF"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}